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Abstract
Pulmonary surfactant is a complex mixture of lipids and proteins that is essential for postnatal function. Surfactant is
synthesized in alveolar type II cells and stored as multi-bilayer membranes in a specialized secretory lysosome-related
organelle (LRO), known as the lamellar body (LB), prior to secretion into the alveolar airspaces. Few LB proteins have been
identified and the mechanisms regulating formation and trafficking of this organelle are poorly understood. Lamellar bodies
were isolated from rat lungs, separated into limiting membrane and core populations, fractionated by SDS-PAGE and
proteins identified by nanoLC-tandem mass spectrometry. In total 562 proteins were identified, significantly extending a
previous study that identified 44 proteins in rat lung LB. The lung LB proteome reflects the dynamic interaction of this
organelle with the biosynthetic, secretory and endocytic pathways of the type II epithelial cell. Comparison with other LRO
proteomes indicated that 60% of LB proteins were detected in one or more of 8 other proteomes, confirming classification
of the LB as a LRO. Remarkably the LB shared 37.8% of its proteins with the melanosome but only 9.9% with lamellar bodies
from the skin. Of the 229 proteins not detected in other LRO proteomes, a subset of 34 proteins was enriched in lung
relative to other tissues. Proteins with lipid-related functions comprised a significant proportion of the LB unique subset,
consistent with the major function of this organelle in the organization, storage and secretion of surfactant lipid. The lung
LB proteome will facilitate identification of molecular pathways involved in LB biogenesis, surfactant homeostasis and
disease pathogenesis.
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Introduction
The lung is composed of a tubular branching network that
terminates in sac-like structures (alveoli) where gas-exchange
occurs. The air-blood barrier consists of thin type I epithelial cells
that cover 95% of the alveolar surface [1], a basal lamina and the
underlying capillary endothelium. Alveolar structure is critically
dependent on the spreading of a phospholipid-rich film,
pulmonary surfactant, at the air/liquid interface on the epithelial
side of the air-blood barrier [2,3]. Surfactant insufficiency, due to
premature birth, or inactivation, due to acute lung injury, results
in increased surface tension and alveolar collapse leading to
decreased gas exchange and respiratory distress syndrome [4].
Surfactant is a mixture of proteins (1–2% surfactant protein (SP)-
B and SP-C) and lipids (80% phospholipids and ,10% neutral
lipids) that is synthesized by alveolar type II epithelial cells [5]. The
complex is stored in specialized secretory organelles (lamellar
bodies, LB) in the form of tightly packed, concentric bilayer
membranes. Regulated release of surfactant into the airspaces
maintains the alveolar surfactant film, which is continually turned
over [6]. Spent alveolar surfactant is degraded by alveolar
macrophages or internalized by type II cells for degradation or
recycling back to the LB [7]. Therefore, the LB plays an important
role in integrating the surfactant biosynthetic and recycling
pathways to maintain the intracellular surfactant pool.
The process of LB maturation is poorly understood [5].
Surfactant phospholipids are synthesized in the ER but the
pathway(s) by which they are transported to and selectively
accumulated in LBs is not clear. ABCA3 likely plays an important
role transporting phosphatidylcholine (PC) and phosphatidylgly-
cerol (PG) across the limiting membrane and into the LB [8–12]:
however, it is not known if other lipid ‘‘importers’’ reside in the LB
membrane or if there is a retrograde transport pathway for
removal of specific lipid species from the LB. Also, the mechanism
of surfactant lipid incorporation into highly organized membranes
is not well understood, although SP-B certainly contributes to this
process [13,14]. Importantly it is not known how the biosynthetic
and recycling pathways are integrated to maintain cellular
surfactant homeostasis. As a first step towards answering these
and other questions related to LB biogenesis, we have identified
the rat LB proteome. In all, 562 LB proteins were identified,
significantly expanding a previous study that detected 44 proteins
[15].
Materials and Methods
Antibodies directed against mature SP-B, SP-C, ABCA3,
lysozyme and b actin were obtained from Seven Hills Bioreagents
(Cincinnati, Ohio). Anti-calnexin and anti-PDIA3 antibodies were
obtained from Sigma-Aldrich (St. Louis, MO). Anti-BiP, anti-
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Bioreagents (Ann Arbor, MI), Imgenex (San Diego, Ca), and
Novus Biologicals (Littleton, CO) respectively. Anti-AGER
antibody was purchased from Abcam Inc. (Cambridge, MA).
Lamellar body isolation
Lamellar bodies were isolated from rat lungs as described by Gil
and Reiser [16] and modified by Jobe, et al. [17]. Adult male
Sprague Dawley rats (200–300 grams) were purchased from
Charles River. Rats were euthanized and the lungs were
repeatedly lavaged with 5 ml of PBS via an endotracheal catheter
to remove extracellular surfactant. The first two bronchoalveolar
lavage fluid (BALF) samples were centrifuged at 5006g for ten
minutes and saved for western blot analysis. Lung tissue was
minced and homogenized in 250 mM sucrose/PBS and centri-
fuged in a swinging bucket rotor for 5 minutes at 10006g at 4uC.
The resultant supernatant was layered on top of a discontinuous
PBS/sucrose gradient and centrifuged at 100,0006g for 60
minutes at 4uC in a Beckmann Optima L centrifuge with a
SW28 swinging bucket. The lamellar body fraction was recovered
at the interface between 0.45 M and 0.65 M sucrose. All animal
protocols were approved by The Institutional Animal Care and
Use Committee (protocol #0D04031) and complied with the
American Association of Laboratory Animal Care guidelines and
the relevant NIH regulations.
Limiting membrane protein isolation
Isolated LBs were incubated for 30 minutes with 10 mM sulfo-
NHS-SS-Biotin in saline on ice. Excess glycine was used to
consume unreacted sulfo-NHS-SS-Biotin. The samples were
treated with an equal volume of 0.2 M Na2CO3 (pH 11.3) in
saline for 30 minutes on ice to remove peripheral membrane
proteins. Stripped lamellar bodies were centrifuged at 100,0006g
for 60 minutes, 4uC using a SW55TI swinging bucket. The pellet
was washed with PBS, and then lysed with RIPA buffer. To isolate
biotinylated proteins, the lysate was passed through a tetralink
tetrameric avidin resin (Promega, Madison, WI) column. Protein
that did not bind to the column was kept for analysis of the inner
core of the LB. Limiting membrane proteins were eluted from the
column using b-mercaptoethanol in 25 mM ammonium bicar-
bonate.
Protein separation, digestion and identification
In order to maximize the number of proteins that could be
identified from each of the LB subfractions, multiple sample
preparation strategies were employed prior to mass spectrometry.
For the primary approach, LB, limiting membrane enriched
(LME), and limiting membrane depleted (LMD) fractions were
solubilized directly in Laemmli buffer, separated by SDS-PAGE
on a 16 by 18 cm 4–20% Tris/Glycine gel (Jules Biotechnologies
Inc., Milford, CT), run on a Hoefer SE400 electrophoresis system
(Hoefer Inc., Holliston, MA) and visualized by Imperial protein
stain (Thermo Fisher Scientific Inc., Rockford, IL). Each lane was
then cut into a grid of 15, 0.5 cm segments. The 15 samples from
each lane were prepared for mass spectrometry by reduction with
dithiothreitol, alkylation with iodoacetamide, trypsin digestion and
peptide recovery, all as described previously [18]. The resulting
peptides from each gel region were concentrated in a SpeedVac
and analyzed by nanoLC-MSMS on a ThermoFisher LTQ linear
ion trap mass spectrometer equipped with an Eksigent nanoLC
system and a 15060.1 mm C18 ChromolithH monolithic column
(Merck KGaA, Darmstadt, Germany). The LTQ MS system was
optimized such that peptide signals that produce ion intensities at
1.5 times above the noise level were subjected to automated MS/
MS fragmentation. Individual ion masses were permitted to be
captured and fragment twice after which they were subsequently
excluded for 1.5 minutes. This method produced .10,000
fragmentations with sub-femtomole sensitivity over a typical 90
minute nanoLC-MS/MS separation. The collective MS/MS
spectral data from the 15 gel regions for each of the LB fractions
were merged and searched against NCBInr database (filtered for
rodent entries) for protein identification using the Mascot (Matrix
Science, Boston, MA) search algorithm on an in house 8 processor
proteomics server. Positive protein identifications were based on a
total Mascot score $75 with a p-value at 0.005.
Given the high lipid content of LBs and the number of known
hydrophobic proteins present in these fractions, intact LBs were
also subjected to pressure cycling technology (PCT) extraction
using a Barocycler NEP2320 (Pressure BioSciences Inc., (PBI),
South Easton, MA) and the ProteoSolve-SB reagent kit (PBI).
Briefly, isolated LBs (,1 mg protein) were concentrated into PBI
Pulse tubes by SpeedVac, resuspended in ProteoSolve-SB,
subjected to 20 cycles of 35,000 psi pulse for 20 seconds each to
disrupt the tissue and the resulting protein extracts isolated by
centrifugation [19]. The protein fraction was dried, dissolved in
Laemmli buffer and separated by SDS-PAGE as described above.
Gridded sections of the gel were prepared, digested and identified
by mass spectrometry as described above.
Transmission Electron Microscopy (TEM)
Tissue, LB processing and immunogold labeling were per-
formed as previously described [20]. Electron micrographs of LBs
were acquired at a magnification of 80,000X using a Hitachi H-
7600 TEM (Hitachi High- Technologies America, Inc., Pleasan-
ton, CA) equipped with a 2000 by 2000 pixel TEM CCD digital
camera (Advanced Microscopy Techniques, Danvers, MA). To
determine if BiP, mature SP-B, or ABCA3 localized to specific
compartments in the LB, gold counts registered on the limiting
membrane and lamellar lipid layer were tabulated and analyzed
by the relative labeling index (RLI), as described by Mayhew et al.
[21]. LB compartments that had higher than expected RLI (p-
value,0.05) and significantly higher partial x
2 values compared to
other compartments were considered to be significantly labeled.
Real Time Polymerase Chain Reaction
Tissues were collected from embryonic (E) mice, flash frozen in
liquid nitrogen and stored at 280uC. Type II cells were isolated
from 6 week old female mice as previously described [22].
Messenger RNA was isolated from cells/tissue using RNeasy
(Qiagen, Valencia, CA). Complementary DNA was generated
using iScript (BioRad, Hercules, CA). Real time polymerase chain
reaction was performed with 25 ng/sample cDNA on a 7300
Real-Time PCR System using Taqman gene expression primers
(Applied Biosystems Inc. Foster City, CA). Relative quantification
of transcripts was determined by normalization to b-actin.
Results
Proteomic analyses were performed on lamellar bodies isolated
from rat lungs. Of particular interest to these analyses were the
proteins of the limiting membrane, as this subpopulation is likely
involved in the biogenesis and maturation of the organelle. To
enrich for limiting membrane proteins, surface accessible free
amines on isolated LBs were conjugated to sulfo-NHS-SS-biotin.
Biotinylated LBs were subsequently washed with Na2CO3 to strip
cytoskeletal proteins, lysed in RIPA buffer and loaded onto an
avidin column. The column was washed extensively and bound
proteins were eluted by reduction of the biotin conjugate. Proteins
Lamellar Body Proteome
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core LB proteins, while the eluted fraction represented enrichment
of LB limiting membrane proteins (Figure S1). Lamellar bodies
lysed before or during biotinylation resulted in some core proteins
being labeled and co-isolated with the limiting membrane fraction.
The purity and integrity of the LB preparations was assessed by
western blotting and electron microscopy. Cryo-TEM performed
on LBs prior to Na2CO3 stripping detected largely intact
organelles with organized lamellae and continuous limiting
membranes (Figure 1A). The lamellar body proteins, surfactant
protein B (SP-B), lysozyme and surfactant protein C (SP-C)
(Figure 2B) were progressively enriched in lung homogenates, type
II cells and isolated LBs, consistent with significant purification of
the LB isolate. Subsequent treatment of LBs with Na2CO3 further
enhanced purity: sodium carbonate stripping greatly reduced the
content of actin (Figure 1C) and Clic5 (not shown) in the LB and
limiting membrane fractions with consequent enrichment in the
stripping buffer. In contrast SP-C (Figure 1D) was not removed by
stripping buffer and was detected in the limiting membrane
depleted (LMD) fraction. The LB limiting membrane protein,
ABCA3 (Figure 1E), was not removed by Na2CO3 stripping and
was recovered in the limiting membrane enriched (LME) fraction,
as expected. Together these results are consistent with minimal
perturbation of LB structure during the isolation procedure.
The LB proteome was compiled from MS analyses of the three
LB fractions (intact LB, LME and LMD). A total of 455 proteins
were detected at least once with a Mascot score $75: 351 proteins
were detected in the intact LB fraction and 280 proteins were
detected in the LME and LMD fractions (184 and 96 proteins,
respectively). Many proteins were identified in both the LMD and
LME fractions, likely related to failure of some proteins to bind the
avidin matrix or retention of biotinylated core proteins on the
column, respectively. Proteins were therefore assigned as LB
limiting membrane (157) or LB core (87 proteins) based on their
Mascot scores (Table S1); 211 proteins were not assigned to either
compartment because the protein was detected only in the intact
LB fraction or because the LME and LMD Mascot scores were
very similar. Ribosomal proteins (13 in total, Table S2) were
excluded in subsequent tables and analyses because these proteins
are contaminants of many organelle proteomes [23]. As an
alternative method to identify LB proteins, PCT was performed on
stripped LBs to delipidate the sample prior to SDS-PAGE and MS
analysis. Ninety-four of the 291 proteins detected by this method
(Table S3) were not detected by the conventional approach,
bringing the total number of proteins to 562. The entire 562
protein dataset was then used to interrogate archived microarrays
of isolated, mouse type II epithelial cells (n=8; [24] and
unpublished data, available upon request). Twenty-three proteins
(4%) were not represented on the Affymetrix chip and thus
expression data are unavailable for this subset, while another 65
proteins (12%) were not expressed or expressed at low levels in the
type II cell. Expression of the remaining 474 proteins (88%) was
confirmed in type II cells. The broad representation of type II cell
proteins in the LB proteome further confirms successful isolation
of LBs from lung homogenates.
Like other organelles, the limiting membrane of the LB is
expected to have a substantial number of transmembrane proteins;
however, because the LB is filled with tightly packed bilayer
membranes, the core protein transmembrane content is also
expected to be very high. Proteins in each fraction were
categorized as soluble, membrane-associated or membrane using
the gene ontology database (http://www.ebi.ac.uk/GOA/). Each
fraction, including the core LMD fraction, contained 33 to 42%
transmembrane proteins (Figure 2A). These ranges are consistent
with the previously reported ranges for ER and lysosomal
membrane proteins [23]. The content of hydrophobic proteins
(transmembrane + membrane associated) was very similar for the
LME (60%) and LMD (57%) fractions consistent with the
membrane cargo of the LB.
In order to assess the potential contribution of other organelles
to the LB proteome, the subcellular localization of each protein
was identified using the Gene Ontology Annotation Database and
by cross-referencing with proteomes of other lysosome-related
organelles (Figure 2B and Table S2). Lamellar bodies are
lysosomal-like organelles that communicate extensively with both
the bioysynthetic and endocytic pathways. Lysosomal proteins
were well-represented in all three fractions as were proteins
associated with the secretory and endocytic pathways (plasma
membrane, secreted, vesicle and ER). Only a small number of
proteins (,6%) were identified from the nucleus, mitochondria or
Golgi consistent with minimal contamination from these com-
partments. The high concentration of cytoskeletal proteins was
expected as the LB surface is densely covered by actin (see
Figure 1C) [25].
As with other lysosome-like organelles, a large number of ER
proteins were detected in the LB proteome. Persistent co-
purification of ER proteins could represent microsomal contam-
ination and/or true localization in the LB. To begin to address this
issue the distribution of the abundant ER chaperone BiP (Mascot
score =1415) was assessed in intact lamellar bodies. BiP was
detected by western blotting of lung homogenates, isolated type II
cells and isolated LB but not BALF (Figure 3A). Immunogold
labeling of isolated LBs (Figure 3B) and lung tissue sections (not
shown) demonstrated that BiP was peripherally distributed in the
LB in close approximation to the limiting membrane. Quantitative
analyses of gold particles provided further support for this
conclusion (Figure 3C). BiP counts were detected primarily at
the limiting membrane (P,0.001) similar to ABCA3, a known LB
limiting membrane protein: in contrast, SP-B counts were
predominantly distributed over the internal membranes
(P,0.001) as expected (Figure 3C). These findings, coupled, with
lack of detection of BiP in BALF (Figure 3A), suggested that this
ER protein accumulates in the LB but is not secreted, perhaps
because of its association with the inner surface of the limiting
membrane. In addition to BiP, calnexin (Mascot score =438) was
also detected in LBs by immunogold labeling of isolated LBs
(Figure S2A). Further, isoforms of the ER chaperone, protein
disulfide iscmerase family A, member 3 (PDIA3, Mascot score
=882), were detected in LBs by confocal microscopy of lung tissue
sections (Figure S2B). Given these preliminary findings, the
significant enrichment of ER proteins in the LB (Table S4) and
the presence of ER proteins in the proteomes of 7 other LROs
[23], we conclude that a subset of ER proteins is present in the LB.
The number of ER proteins resident in the LB and the manner in
which they are transported between the two organelles remains to
be established.
Lamellar body proteins not present in other lysosome related
organelles (LRO) proteomes are collected in Table 1. The major
function of the LB is the assembly and storage of surfactant
phospholipids for regulated release into the alveolar airspaces.
Consistent with this function many of the proteins unique to the
LB are involved in lipid or ion transport. In addition to ABCA3
(Mascot score =673) these include ATP8A1 (Mascot score =163),
ABCA8a (Mascot score =107), StarD9 (Mascot score =76),
Deleted in Liver Cancer 1/StarD12 (Mascot score =75), ATP1a1
(Mascot score =672), Major Vault Protein (Mascot score
=546), SLC4A1 (Mascot score =393), and ATP2B4 (Mascot
score =364). ATP8A1 and ABCA8a were the focus of further
Lamellar Body Proteome
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poorly characterized member of the ABCA subfamily of lipid
transporters. MS analyses detected ABCA8a exclusively in the LB
limiting membrane fraction (Table S1). Expression of ABCA8a
mRNA in lung tissue increased modestly between E13-E17 with a
more pronounced increased in the perinatal period (E18-PND1)
and a significant increase in juvenile and adult lung (Figure 1A).
Similarly, expression of mRNA encoding ATP8A1, increased from
E16-E18 with a more pronounced increase in postnatal lung tissue
(Figure 4A). ATP8A1 has been implicated in transport of several
phospholipids species and, like ABCA8a, was exclusively detected
in the LME fraction. Identification of these candidate phospho-
lipid transport/transfer proteins is consistent with their predicted
role in transport of lipid substrates across the LB limiting
membrane.
Pulmonary surfactant is actively recycled from the alveolar
spaces likely resulting in the incorporation of some endosomal
proteins in the LB. Consistent with this hypothesis a number of
endocytic pathway related proteins were identified, including
adaptor-related proteins AP2A2 (Mascot score =589), and AP2B1
(Mascot score =356), clathrin (CLTC, Mascot score =1798) and
annexins A1, A2 and A6 (Mascot score =254, 565 and 1551
respectively). Three EH-domain (EHD) containing proteins,
previously implicated in endocytic trafficking, were also identified
in the LME fraction [26,27]. EHD2 and EHD4 had high Mascot
scores (1371 and 1019 respectively) and were strongly detected in
mouse lung compared to other tissues by western blotting
(Figure 5A and B). Although EHD2 was enriched in isolated
LB, the signal was lower in type II cells compared to whole lung
lysate, suggesting that EHD2 may be expressed in multiple lung
cell types (Figure 5C). In contrast EHD4 was detected predom-
inantly in type II cells with lower expression in the LB fraction,
suggesting that EHD4 is distributed among multiple subcellular
compartments in the type II cells (Figure 5D). Unexpectedly,
EHD4 was also found in the BALF, consistent with release into the
airspaces.
Multiple proteins involved in airway defense were detected in
the LB proteome including antimicrobial and antioxidant proteins.
Previously identified proteins in this category included surfac-
tant protein A (Mascot score =466) and lysozyme (Mascot
score =232). Defense proteins not previously detected in the LB
include the paraoxonase proteins PON2 and PON3 (Mascot
scores 115 and 300 respectively), which are reported to have both
anti-oxidant and antimicrobial activities [28]. In addition the
antioxidant proteins dolichyl-diphosphooligosaccharide-protein
glycosyltransferase (DDOST, Mascot score =279) and advanced
Figure 1. Characteristics of isolated lamellar bodies. (A) Cryo-TEM of LB samples obtained before Na2CO3 stripping or sulfo-NHS-SS-biotin
treatment. (B) Enrichment of lysozyme, mature SP-B and mature SP-C during LB isolation. (C–E) The effect of Na2CO3 mediated peripheral protein
stripping on LB protein distribution. Start is the initial LB sample, LB is the LB sample after Na2CO3 treatment, Na2CO3 is the Na2CO3 solution after
stripping, LME refers to limiting membrane enriched fraction and LMD refers to limiting membrane depleted fraction. (C) b-actin protein, (D) mature
SP-C and (E) ABCA3 protein within these fractions. All samples were normalized to total protein content.
doi:10.1371/journal.pone.0016482.g001
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=179) were also detected. AGER is highly expressed in the lung
but has not previously been associated with the LB. Both
membrane (Mw,50 kDa) and soluble (Mw,45 kDa) forms of
AGER were detected by western blotting of lung homogenates
(Figure 5E). Interestingly, soluble AGER was significantly enriched
in the LB and was detected in BALF, suggesting that the type II
cells may be an important source of this anti-oxidant molecule.
The identity of the other AGER isoform (Mw,34 kDa) has not
been established but may represent unglycosylated soluble isoform
[29]. Collectively these findings support the conclusion that, in
addition to packaging/secretion of pulmonary surfactant, the LB
plays an important role in airway defense.
Discussion
For this study, LBs were isolated from rat lung homogenates by
flotation on a discontinuous sucrose gradient. This procedure
isolated largely intact organelles as indicated by TEM analysis of
LB morphology, significant enrichment of known core LB proteins
Figure 2. Characteristics of LB proteome. (A) Distribution of membrane proteins in the proteome with respect to the 3 LB fractions. (B) Predicted
subcellular localization of proteins in the LB, LMD and LME fractions.
doi:10.1371/journal.pone.0016482.g002
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membrane protein ABCA3 to the LME fraction and SP-B to the
LMD fraction. Initial attempts to digest and identify proteins
directly by single LC-MS analyses of isolated intact LBs resulted in
the detection of primarily actin peptides, consistent with the
previously reported actin mesh surrounding LBs [25,30]. Sodium
carbonate treatment greatly reduced the actin signal and, coupled
with SDS-PAGE and the gel gridding method described in the
methods section, permitted detection of a total of 468 non-
redundant proteins in the intact LB, LME, and LMD fractions
(Table S1). Further extraction of sodium carbonate-treated, intact
LBs by pressure cycling technology (Table S3) resulted in detection
of another 94 proteins, bringing the total number of unique
identities to 562. This number is almost certainly an underesti-
mation as relatively few Rab proteins were detected and
preliminary western blot analyses of the sodium carbonate,
actin-rich fraction identified several proteins not detected by MS
but likely to be associated with the LB limiting membrane (e.g.,
StarD10, data not shown).
Proteins categorized as mitochondrial, nuclear or Golgi
comprised #6% of the LB proteome, consistent with minor
contamination from these subcellular compartments. The fraction
of proteins classified as cytosolic (,14%) was quite similar to that
recently reported for LBs isolated from skin (,18%) [31]. ER
proteins comprised ,13% of the lung LB proteome, a finding that
is similar to the range reported for other LROs (11–27%) [23].
Lysosomal, vesicle, plasma membrane and cytoskeletal proteins
comprised 59–65% of the proteome consistent with the lysosomal
nature of the lamellar body and extensive communication of this
organelle with the endocytic and secretory pathways in the type II
epithelial cells. Although the dynamic interaction of these
organelles complicates assignment of individual proteins to the
LB proteome or as contaminants, this broad compartmental
overlap is shared by other secretory LROs [23].
The distinguishing feature of LBs is the high content of lipids
that are packaged as membrane lamellae. To date, there is only
one study of the lung LB proteome that identified 44 proteins in
isolated rat lung LBs [15]. Thirty-three of these proteins were
detected in the current study and none of the other 11 proteins
were unique to the LB (Table 1). The discrepancy in the number
of LB proteins identified in the current study (562) and the report
by Wang, et al. [15] is likely related to different MS procedures
Figure 3. BiP distribution in LBs. (A) Western blot for BiP in HEK293 cells, whole lung, isolated type II cells, isolated LBs and BALF. Samples were
normalized to protein content. (B) Immunogold labeling for BiP in isolated rat LB. (C) Relative labeling index (RLI) of isolated rat LBs labeled by
immunogold for ABCA3, mature SP-B and BiP.
doi:10.1371/journal.pone.0016482.g003
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number of proteins in the LB proteome, a recent study of LBs
isolated from human skin identified 984 proteins [31]. Compar-
ison of the lung and skin LB proteomes revealed a surprisingly
small number of shared proteins (9.8%). This finding likely reflects
the functional specialization of the two LB populations: skin LBs
store lipids primarily involved in barrier function, proteases and
glycosidases related to desquamation, and antimicrobial peptides;
lung LBs store phospholipids required for surface tension
reduction in the alveolar spaces, proteins essential for the
organization of intracellular and extracellular surfactant mem-
branes, and distinct proteins involved in innate host defense.
Proteins shared by skin and lung LBs were largely associated with
or components of the LB limiting membrane, including proteins
involved in ion transport or vesicle trafficking.
The lung LB proteome was compared to proteomes of 7 other
LROs, recently reviewed by Hu, et al. [23], including lysosomes,
endosomes, melanosomes, neuromelanin granules, exosomes,
platelets, and synaptosomes. Unexpectedly, lung LBs were found
to be most similar to melanosomes (37.8% shared proteins).
Furthermore, hypergeometric distribution analyses of the LB
proteome with human GO annotation (Table S4) identified the
melanosome as the compartment most similar to the LB
(P=2.5610
230). Melanosomes are LROs specialized for the
synthesis and storage of the pigment melanin. As for skin LBs,
many proteins shared by melanosomes and lung LBs were
Table 1. Proteins unique to the LB relative to other LROs.
Mascot Score
Rat Symbol Human Symbol NAME LB LM Core
ABCA3 ABCA3 ATP-binding cassette, sub-family A (ABC1), member 3 272 673 120
ABCA8A ABCA8A ATP-binding cassette sub-family A member 8-A 107
AGER AGER Advanced glycosylation end product-specific receptor 179 123
ALCAM ALCAM Activated leukocyte cell adhesion molecule 161
ATP8A1 ATP8A1 ATPase, aminophospholipid transporter (APLT), Class I, type 8A, member 1 163 119
BCAM BCAM Basal cell adhesion molecule 181 148
Car4 CAR4 Carbonic anhydrase 4 * 347
CES3 CES3 Carboxylesterase 3 556
CP CP Ceruloplasmin 905 136
CRIP2 CRIP2 Cysteine-rich protein 2 75
CYP2F2 CYP2F2 Cytochrome P450, family 2, subfamily f, polypeptide 2 252
CYP2S1 CYP2S1 Cytochrome P450, family 2, subfamily S, polypeptide 1 139
CYP4B1 CYP4B1 Cytochrome P450, family 4, subfamily B, polypeptide 1 174 75 177
EHD2 EHD2 EH-domain containing 2 1371 447 384
ENPEP ENPEP Glutamyl aminopeptidase 500 261
Fabp1 FABP1 Fatty acid binding protein 1, liver * 840
FMO1 FMO1 Flavin containing monooxygenase 1 268
Gstm2 GSTM2 Glutathione S-transferase, mu 2 * 276
ITGA3 ITGA3 Integrin, alpha 3 94
JUP JUP Junction plakoglobin 160
LMO7 LMO7 LIM domain 7 75
LYZ LYZ Lysozyme 199 98 232
MYO1B MYO1B Myosin IB 97
PON3 PON3 Paraoxonase 3 300 127 96
RASIP1 RASIP1 Ras interacting protein 1 229
SDPR SDPR Serum deprivation-response protein 575 75 168
SEPT4 SEPT4 Septin 4 88
SFTPA1 SFTPA1 Surfactant, pulmonary-associated protein A 319 75 466
SFTPB SFTPB Surfactant, pulmonary-associated protein B 75 156
SFTPC SFTPC Surfactant, pulmonary-associated protein C 294
SLC6A14 SLC6A14 Solute carrier family 6 member 14 135 75
SLCO2A1 SLCO2A1 Solute carrier organic anion transporter family, member 2A1 120
SYNE2 SYNE2 Spectrin repeat containing, nuclear envelope 2 82
THBD THBD Thrombomodulin 211 163
*Proteins identified by PCT extraction.
doi:10.1371/journal.pone.0016482.t001
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however, the extent of overlap between lung LB and melanosome
was much greater than that for lung and skin LBs. Comparison of
the LB proteome with the proteomes for early (immature) and late
(mature) melanosomes revealed greater overlap between the LB
and early melanosome (Table S5). Collectively, these findings
suggest that there is considerable overlap in the biogenesis of LBs
and melanosomes. This conclusion is supported by the observa-
tions that mutations that disrupt melanosome biogenesis are
frequently associated with both hypo-pigmentation disorders and
pulmonary fibrosis in patients with Hermansky Pudlak Syndrome
(HPS) [32] and lamellar body structure and/or surfactant
secretion is affected in several different HPS mouse mutants
[33–37].
To identify proteins that contribute to the specialized functions
of lung LBs, we compared the 9 LRO proteomes and selected the
229 proteins that were unique to the LB proteome. These data
were subsequently filtered to identify proteins with confirmed
expression in type II epithelial cells (by comparing the unique
protein subset to archived microarrays of mouse type II epithelial
cells) and elevated expression in lung compared to other tissues.
This approach identified 35 proteins, including 4 proteins
generally recognized as LB constituents (SP-A, SP-B, SP-C, and
ABCA3) (Table 1); three other proteins typically regarded as LB
constituents (SP-D, napsin A, and lysozyme) were also present in
the lysosome, exosome and skin LB proteomes respectively and
thus were not included in this subset.
In addition to ABCA3, 2 potential lipid transport proteins
(ABCA8a and ATP8A1) were detected in the LB unique subset of
proteins. ABCA8a is a member of the ABCA subfamily of ABC
transporters and shows extensive similarity to ABCA5 (59%),
ABCA6 (69%), ABCA9 (77%), and ABCA10 (73%), all of which
are expressed in brain. Consistent with localization of family
members to lipid-rich tissues, ABCA8a was previously shown to
transport the lipophilic substrates digoxin and leukotriene
C4 [38,39]. Whether ABCA8a functions as a phospholipid
transport protein at the LB membrane remains to be tested.
ATP8A1/ATPase II facilitates ATP-dependent transport of
phosphatidylserine (PS) across vesicle membranes in vitro and has
been implicated as the ‘‘flippase’’ that maintains PS asymmetry in
the plasma membrane [40,41]. The yeast homolog of ATP8A1,
Drs2p, is localized to the Golgi through interaction with an
accessory protein, Cdc50p [42]. The accessory protein may
influence both the intracellular localization and substrate prefer-
ence of the transporter complex. Assuming a membrane
orientation similar to the plasma membrane flippase (i.e. such
that phospholipid is transferred to the cytosolic leaflet), one
possible function for ATP8a1 would be to ‘‘recondition’’ surfactant
internalized via the recycling pathway by removing undesirable
phospholipid components such as lysoPC from the LB for
Figure 4. Relative mRNA expression levels of (A) ATP8A1 and (B) ABCA8a, as assessed by real-time polymerase chain reaction. Data
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function of ATP8A1 and ABCA8a and the role of these potential
phospholipid transport proteins in the formation and/or remod-
eling of surfactant membranes.
Several other proteins with lipid-related functions were detected
in the LB unique subset, including the prostaglandin transporter
SLCO2A1, the myelin associated protein periaxin (PRX), a fatty
acid binding protein (Fabp1), a phospholipid binding protein
(SDPR), and carboxylesterase 3 (CES3). These proteins have not
previously been localized to the LB and, with the possible
exception of CES3, their function in this compartment is not
known. Carboxylesterase converts large aggregate forms of
surfactant to smaller vesicular forms in vitro and is postulated to
play a role in metabolism of surfactant in the airspaces. Previous
studies detected carboxylesterase activity in bronchoalveolar
lavage fluid from rats [43] and mice [44,45] that was identified
as CES1 (liver carboxylestrase 1/ES-2), an enzyme that is 72%
identical to CES3. CES1 was not detected in the LB proteome and
thus the cellular source of this enzyme in the airspaces is unclear.
Whether CES3 and/or CES1 are part of a redundant system
required for turnover of the alveolar surfactant pool remains to be
determined.
The LB unique subset also contained several proteins that may
contribute to antioxidant function in the lung, including PON3,
ceruloplasmin, glutathione S-transferase and AGER/RAGE. The
identification of RAGE in the LB proteome was unexpected as this
protein has been reported to be a marker for type I alveolar
epithelial cells [29]. Western blotting detected predominantly the
soluble isoform of RAGE in both isolated LBs and BALF. Although
we cannot exclude the possibility that RAGE is a contaminant, we
note that other type I epithelial cell markers (e.g. T1a and
aquaporin 5) were not detected in the LB proteome; further, there
are conflicting reports regarding the expression pattern of RAGE in
the lung [46,47]. Thus, it is possible that RAGE is synthesized and
secreted by type II epithelial cells or internalized into LBs from the
airspaces via the endocytic pathway.
In summary we have identified 562 proteins in isolated rat lung
LBs. This proteome reflects a highly dynamic organelle that
communicates extensively with the biosynthetic, secretory and
endocytic pathways. The lung LB proteome significantly overlaps
other LRO proteomes and shows striking similarity to the
melanosome with surprisingly little similarity to skin LBs. Proteins
with lipid-related functions comprise a significant proportion of
the LB unique protein subset, consistent with the major function of
this organelle in the organization, storage and secretion of
surfactant membranes. Although the molecular pathways involved
in maturation of the LB remains a significant knowledge gap,
identification of multiple phospholipid transport proteins and ER
Figure 5. Western blot for LB proteome proteins. Samples were normalized to protein content. Distribution of (A) EHD2 and (B) EHD4 in mouse
tissues. Distribution of (C) EHD2, (D) EHD4 and (E) AGER in lung homogenates, type II cells, isolated LBs and BALF.
doi:10.1371/journal.pone.0016482.g005
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involving non-vesicular transfer of phospholipids between the ER
and LB. Finally, in addition to proteins that may modulate
organization of extracellular surfactant membranes, the lung
contains proteins with antimicrobial and antioxidant properties
that likely contribute to alveolar homeostasis.
Supporting Information
Figure S1 Fraction scheme for isolation of limiting membrane
proteins from lamellar body.
(TIF)
Figure S2 Immunogold localization for calnexin in (A) isolated rat
LB.Goldparticlesareproximaltolamellarbodylimitingmembrane.
Scale bar =250 nm. (B) Double label confocal microscopy of mouse
lung tissue. Anti-SP-B (green) and anti-PDIA3 (red) colocalize at the
lamellar bodies in type II cells. Scale bar =10 mm.
(TIF)
Table S1 Rat lamellar body proteome organized by predicted
localization to the limiting membrane or core (lumen) of the LB.
Proteins detected in two or more fractions (i.e. LB, LME or LMD)
received more than one Mascot score. In some cases, one the
Mascot scores was below the threshold (indicated by *); at least one
Mascot score had to be .75 in order for the protein to be included
in the proteome.
(DOC)
Table S2 Subcellular localization of rat LB proteins selected
from the gene ontology database (http://www.ebi.ac.uk/GOA/).
(DOC)
Table S3 LB proteins detected only by PCT extraction of the
LB sample.
(DOC)
Table S4 The LB proteome was analyzed for subcellular
compartment enrichment by hypergeometric distribution using
GO annotations of the human genome as reference background
[48]. The Benjamini-Hochberg procedure was used to control
family-wide false discovery rate #0.001 [49]. From the proteins
identified in the current LB proteomics study, 16.7% (85 proteins)
are known ER residents. The overlap of the LB and ER proteins is
significant (P=1.2610
214). Gene Ontology Analysis was per-
formed using public available web-based tool DAVID [48].
Overrepresented cellular components were selected at the
threshold of False Discovery Rate (FDR) #0.005, minimum gene
counts belonging to an annotation term $3% and Fold
enrichment .2. Hypergeometric distribution was used to
determine the degree of enrichment (PValue), FDR was
determined using Benjamini-Hochberg procedure [49]. Fold
enrichment measures the magnitude of enrichment, i.e. the % of
proteins in LB list with a certain GO term versus the % of proteins
with the same GO term in human genome (background).
(DOC)
Table S5 Comparison of LROs and LB proteome.
(DOC)
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